ARCHIVES

FDA Approves New Indication For Anticoagulant Frangmin

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

Moddelmog Steps Down At Komen For the Cure

November 20, 2009

Cancer Genetics: risk from Three BRCA Mutations Lower Than Expected, NCI Finds

May 23, 1997

Panel Suggests Test Of Paid Advertising For ACS: Roundup

August 7, 1992

Senate Subcommittee Agrees On $1.188 Billion NCI Budgt for FY 1985, $110 Million Increase Over ‘84

June 29, 1984

Evaluation Finds OIG Provides PIs With Flexibility

June 14, 1991

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 23, 1998